Position in CYTK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$11,863,800
+$1,263,867 QoQ
Shares Held
180,000
+7.9% QoQ
Ownership
0.145%
of shares outstanding
% of Portfolio
4.26%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Checkpoint Capital L.P. holds $278,650,517 across 8 Biotechnology names. CYTK ranks #5 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
153,000 | $111,728,250 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,227,200 | $106,729,584 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
262,539 | $25,531,917 | |
| 4 | IRON |
Disc Medicine, Inc.
|
286,661 | $18,329,104 | |
| 5 | CYTK |
Cytokinetics Inc
This page
|
180,000 | $11,863,800 | |
| 6 | SEPN |
Septerna, Inc.
|
100,300 | $2,410,209 | |
| 7 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
40,230 | $1,461,153 | |
| 8 | TRVI |
Trevi Therapeutics, Inc.
|
50,000 | $596,500 |
All Filings in CYTK
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,863,800 | 180,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,599,933 | 166,823 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,065,781 | 37,587 | Shares | Sole | 2025-11-14 | |
| 2024-12-31 | $940,800 | 20,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $24,647,726 | 466,813 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,294,200 | 190,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $13,320,900 | 190,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $19,202,700 | 230,000 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||